Fact CheckerSign in

NCT06473532Completed

TEXT4HF: A Randomized Controlled Trial of a Tailored Text Messaging Intervention to Improve Self-Care in Older Adult Patients With Heart Failure

Source: ClinicalTrials.gov · Last updated 21 Sept 2026

Brief summary (registry, in English)

The goal of this study is to determine whether an individually tailored text messaging intervention can improve self-care in older adult patients with heart failure. The main question it aims to answer are: * Is a tailored text messaging intervention feasible and acceptable among older adult patients with heart failure? * Does tailored text messaging improve self-care in adult patients with heart failure? Participants will be randomly assigned to one of two groups for 12 weeks: 1) intervention (text messaging); or 2) control group. Both groups will receive usual care, which includes regular follow-up visits at the heart failure clinic (standard care), plus a "Discharge Packet for Patients Diagnosed with Heart Failure", developed by the American Heart Association. Both groups will be asked via text messages and/or telephone calls to complete questionnaires at baseline/start, 4 weeks and 12 weeks, about self-care, quality of life, health beliefs, medications, diet, etc. Participants assigned to the intervention group will also receive approximately 5 text messages/week targeting medication adherence, heart-healthy diet, and self-monitoring for 12 weeks.

Status (registry)
Completed
Study type
Interventional
Enrollment
26 (actual)
First submitted
19 Jun 2024
Start date
26 Sept 2024
Primary completion date
10 Feb 2026
Lead sponsor
University of Illinois Chicago
NCT number
NCT06473532

What you commit to

  • Study type: Interventional
  • Participants enrolled: 26
  • From 26 Sept 2024 to the primary completion date, 10 Feb 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Unable to self-manage (take medication, bathe, use the toilet, etc.)

Other illness

  • SAVR/TAVR or Ventricular Assist Device, or Cardiac Resynchronization Therapy (CRT) - implantation, and/or heart transplantation (HTx) scheduled within the next 3 months
  • Advanced Renal disease (i.e., estimated Glomerular Filtration Rate \<25 or Hemodialysis)
  • Cognitive impairment (i.e., Dementia, Alzheimer's)

Other

  • Coronary revascularization, and/or CRT-implantation within the last 30 days (EMR Review)
  • Psychosis
  • Hospice or End-of-life care
  • Currently living in a nursing home

Who the study is looking for

  • ≥50 years of Age
  • HF Stage C, NYHA Class I-IV and on a loop diuretic
  • Own a Mobile phone with Text message plan
  • Ability to speak and read English
  • Suboptimal HF self-care. (SCHFI Score of 3 or less in at least 2 items of any subscale: Self-care maintenance, Symptom Perception, or Self-management)

Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Illinois Chicago
Coordinator of this site? Confirm its status
ChicagoUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.